Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1997-07-01
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536122, A61K 3170
Patent
active
056438923
ABSTRACT:
A method of treating a mammalian patient suffering from a chronic progressive vascular disease (CPVD) characterized by scarring and/or fibrosis to halt the progress of the disease and cause resolution of already-formed scarring or fibrotic lesions. The method consists of the administration to the patient of a pharmaceutical composition containing an effective amount of pentosan polysulfate (PPS) or a pharmaceutically acceptable salt thereof. The oral route of administration is preferred, with total daily dosage of PPS or PPS salt ranging from about 50 to 1200 mg per day.
REFERENCES:
patent: 4820693 (1989-04-01), Gillespie
patent: 4966890 (1990-10-01), Gillespie
patent: 5032679 (1991-07-01), Brandley et al.
Hasdai, et al., Coronary Art. Dis., vol. 5, No. 1, pp. 81-91.
Peten, J. Am. Soc. Neph., vol. 41, p. 780, 111p, Non-Anticoagulant Heparin Suppresses .alpha.11 Collagen mRNA and Reduces Laminin B1 Expression in Sclerotic Glomeruli from Mice Transgenic for Growth Hormone (GH Mice) (1993).
Kaizu, et al., Jap. J. Neph., vol. 35, No. 1, pp. 35-42 (1993).
Floege, et al., Kid. Int., vol. 43, pp. 369-380 (1993).
Striker, et al., Diabetes/Metabolism Rev., vol. 9, No. 1, pp. 37-56 (1993).
Tan, et al., Am. J. Path., vol. 142, No. 2, pp.463-470 (1993).
Kanabrocki, et al., Quat. J. Med., New Series 83, No. 300, pp. 259-282 (1992).
Naparstek, et al., Arth. & Rheum., vol. 33, No. 10, pp. 1554-1559 (1990).
Wardle, J. Int. Med. Res., vol. 20, pp. 361-370 (1992).
Peten, et al., J. Exp. Med., vol. 176, pp. 1571-1576 (1992).
Peten, et al., Am. J. Physiol., vol. 263, pp. F951-F957 (1992).
Striker, et al., Lab. Inv., vol. 64, No. 4., pp. 446-456 (1991).
Pesce, et al., Lab. Inv., vol. 65, No. 5, pp. 601-605 (1991).
Nakamura, et al., Lab. Inv., vol. 64, No. 5, pp. 640-647 (1991).
Tan, et al., Biochem. J., vol. 278, pp. 863-869 (1991).
Wilke, et al., Cleveland Clin. J. Med., pp. 753-754 (Nov./Dec. 1989).
Karnovsky, et al., Ann. N.Y. Acad. Med., vol. 556, pp. 268-281 (1989).
Herbert, et al., Path. Biol., vol. 37, No. 7, pp. 847-850 (1989).
Purkerson, et al., J. Clin. Invest., vol. 81, pp. 69-74 (1988).
Herbert, et al., Artery, vol. 16, No. 1, pp. 1-14 (1988).
Adler, Am. J. Physiol., vol. 255, pp. F781-F786 (1988).
Herbert, et al., Biochem. Pharm., vol. 37, No. 22, pp. 4281-4288 (1988).
Slugen, Int. Urol. Neph., vol. 20, No. 3, pp. 313-314 (1988).
Ichikawa, et al., Kid. Int., vol. 34, pp. 638-644 (1988).
Paul, et al., Thrombosis Res., vol. 46, pp. 793-801 (1987).
Jacques, et al., Artery, vol. 14, No. 4, pp. 209-215 (1987).
Rosenberg, et al., Ann. N.Y. Acad. Science, vol. 454, pp. 270-278 (1985).
Delvos, et al., Blut, vol. 51, pp. 127-136 (1985).
Andrews, et al., Chem. Bio. Interactions, vol. 47, pp. 157-173 (1983).
Golding, et al., Current Ther. Res., vol. 33, No. 2 (1983).
Berthoux, et al., Path. Biol., vol. 25, pp. 33-36 (1977).
Fye, et al., Arch. Intern. Med., vol. 136, pp. 995-999 (1976).
Bone, et al., Kid. Int., vol. 8, pp. 72-79 (1975).
Zimmerman, et al., Nephron, vol. 12, pp. 219-230 (1974).
Suc, et al., Pers. Neph. & Hyper., vol. 1, Pt. 2, pp. 927-947 (1973).
Arieff, et al., Arch. Intern. Med., vol. 129, pp. 77-84 (1972).
Lindeman, Klin. Mbl. Augenheilk, vol. 161, pp. 100-103 (1972).
Freedman, et al., Inv. Urol., vol. 7, No. 5, pp. 398-409 (1970).
Kincaid-Smith, et al., The Lancet, pp. 1360-1363 (1968).
SP.sub.54 Package Insert for pentosanpolysulphate sodium, Bene Arzneimittel GmbH.
Sherman Fred P.
Striker Gary E.
Striker Liliane J.
Baker Norton Pharmaceuticals, Inc.
Peselev Elli
The United States of America as represented by the Department of
LandOfFree
Method of treating chronic progressive vascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating chronic progressive vascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating chronic progressive vascular diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597222